Hardy, Britta and Raiter, Annat (2013) New era in cancer immunotherapy: Twenty years to the discovery of monoclonal antibodies harnessing the immune system to eradicate tumors. Advances in Bioscience and Biotechnology, 04 (04). pp. 34-37. ISSN 2156-8456
ABB_2013042917312572.pdf - Published Version
Download (128kB)
Abstract
The better understanding of the mechanism in which the immune system responds to the developing cancer provided the outcome in a new era in cancer immunotherapy. The tumor suppressive effect on the immune system is caused by negative T cell receptor signaling that abrogate immunity against the cancer cells. Novel monoclonal antibodies that target co-inhibitory receptors on T cells block the tumor induced inhibition of the immune system and enable the immune system to eradicate the tumors. The development of such antibodies started twenty years ago by the preparation of a monoclonal antibody termed BAT. A single administration of the antibody to tumor bearing mice resulted in striking anti tumor activity that was mediated by the lymphocytes. These studies provided a basis for the new era of cancer immunotherapy. The present review summarizes twenty years to the discovery of monoclonal antibodies harnessing the immune system to eradicate tumors.
Item Type: | Article |
---|---|
Subjects: | East India Archive > Biological Science |
Depositing User: | Unnamed user with email support@eastindiaarchive.com |
Date Deposited: | 17 Mar 2023 08:43 |
Last Modified: | 24 Jun 2024 05:22 |
URI: | http://ebooks.keeplibrary.com/id/eprint/557 |